Association between delayed transcatheter aortic valve replacement beyond 6 months and clinical outcomes in severe aortic stenosis: a retrospective observational study.

Authors

Ayumi Omuro, Shinichi Okuda, Yosuke Miyazaki, Masaki Tamitani, Junya Nawata, Yusuke Nakashima, Miho Fujita, Kaori Murakawa, Masamune Uchida, Yuki Furushimo, Hiroshi Kurazumi, Ryo Suzuki, Akihito Mikamo, Takayuki Okamura, Kimikazu Hamano, Motoaki Sano

Published in

Open heart. Volume 13. Issue 2. Sep 18, 2026. Epub Sep 18, 2026.

Abstract

Early intervention for asymptomatic severe aortic stenosis (AS) has shown prognostic benefits; however, some patients undergo transcatheter aortic valve replacement (TAVR) after extended observation owing to mild symptoms or comorbidities. Although guidelines recommend surveillance of 6-12 months, the clinical implications of waiting beyond 6 months remain unclear. We assessed whether TAVR performed >6 months after the diagnosis of severe AS was associated with adverse outcomes.
We retrospectively analysed 149 patients who underwent TAVR for severe AS between January 2021 and December 2023. Patients were classified into early (≤6 months; n=100) and delayed (>6 months; n=49) groups. The primary endpoint was heart failure (HF) hospitalisation or all-cause mortality.
Baseline characteristics were similar between the groups. During a median follow-up of 729 days, the primary endpoint occurred more frequently in the delayed group than in the early group (33% vs 16%, p=0.0134). This excess risk was largely attributable to non-cardiac mortality. In multivariable Cox regression, delayed intervention was independently associated with the primary endpoint (HR 3.47, 95% CI 1.61 to 7.47; p=0.0014); higher Clinical Frailty Scale scores were also associated with this endpoint (HR 1.62, 95% CI 1.07 to 2.42; p=0.0195).
TAVR performed 6 months after severe AS diagnosis was associated with a higher risk of HF hospitalisation or all-cause mortality, with the excess risk predominantly attributable to non-cardiac mortality. These findings emphasise the need for careful clinical surveillance and may support more frequent reassessment in selected high-risk patients.

PMID:
42760097
Bibliographic data and abstract were imported from PubMed on 19 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.